Macrophage mediated protein hydroperoxide formation and lipid oxidation in low density lipoprotein are inhibited by the inflammation marker 7,8-dihydroneopterin

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1783, Issue 6, 2008, Pages 1095-1101

  Firth, Carole A ^a   Crone, Elizabeth M ^a   Flavall, Elizabeth A ^a   Roake, Justin A ^b   Gieseg, Steven P ^a  

^a UNIVERSITY OF CANTERBURY   (New Zealand)

^b CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

Antioxidant; Atherosclerosis; Inflammation; Lipid oxidation; Low density lipoprotein; Macrophage; Neopterin; Protein oxidation

Indexed keywords

7,8 DIHYDRONEOPTERIN; 7,8 DIHYDROXANTHOPTERIN; ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; GAMMA INTERFERON; LIPID; LIPID HYDROPEROXIDE; LOW DENSITY LIPOPROTEIN; NEOPTERIN; PEROXY RADICAL; STATIN; XANTHOPTERIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL STIMULATION; CELL TYPE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE COURSE; DRUG INHIBITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID OXIDATION; MACROPHAGE; MALE; PRIORITY JOURNAL; SYNTHESIS; TISSUE CULTURE;

ATHEROSCLEROSIS; CELL LINE; HEMOCHROMATOSIS; HUMANS; HYDROGEN PEROXIDE; INFLAMMATION; INTERFERON TYPE II; LIPIDS; LIPOPROTEINS, LDL; MACROPHAGES; MONOCYTES; NEOPTERIN; OXIDATION-REDUCTION; OXYGEN; PEROXIDES;

EID: 43549106081     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2008.02.010     Document Type: Article

References (67)

1. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., and Witztum J.L. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320 (1989) 915-924
2. Maor I., and Aviram M. Oxidised low density lipoprotein leads to macrophage accumulation of unesterified cholesterol as a result of lyosomal trapping of the lipoprotein hydrolysed cholesterol ester. J. Lipid. Res. 35 (1994) 803-819
3. Wang X.S., Greilberger J., Ledinski G., Kager G., and Jurgens G. Binding and uptake of differently oxidized low density lipoprotein in mouse peritoneal macrophages and THP-1 macrophages: involvement of negative charges as well as oxidation-specific epitopes. J. Cell. Biochem. 81 (2001) 557-569
4. Reid V.C., and Mitchinson M.J. Toxicity of oxidised low density lipoprotein towards mouse peritoneal macrophages in vitro. Atherosclerosis 98 (1993) 17-24
5. Hardwick S.J., Hegyi L., Clare K., Law N.S., Carpenter K.L.H., Mitchinson M.J., and Skepper J.N. Apoptosis in human monocyte-macrophages exposed to oxidised low density lipoprotein. J. Pathol. 179 (1996) 294-302
6. Martinet W., and Kockx M.M. Apoptosis in atherosclerosis: focus on oxidized lipids and inflammation. Curr. Opin. Lipidol. 12 (2001) 535-541
7. Aviram M., Rosenblat M., Etzioni A., and Levy R. Activation of NADPH oxidase is required for macrophage mediated oxidation of low density lipoprotein. Metabolism 45 (1996) 1069-1079
8. Wood J.L., and Graham A. Reduction of transition metals by human (THP-1) monocytes is enhanced by activators of protein kinase C. Free. Radic. Res. 31 (1999) 367-379
9. Chisolm G.M., Hazen S.L., Fox P.L., and Cathcart M.K. The oxidation of lipoproteins by monocytes-macrophage: biochemical and biological mechanisms. J. Biol. Chem. 274 (1999) 25959-25962
10. Gieseg S.P., Crone E.M., Flavall E.A., and Amit Z. Potential to inhibit growth of atherosclerotic plaque development through modulation of macrophage neopterin/7,8-dihydroneopterin synthesis. Br. J. Pharmacol. (2007) 10.1038/sj.bjp.0707408
11. Huber C., Batchelor J.R., Fuchs D., Hausen A., Lang A., Niederwieser D., Reibnegger G., Swetly P., Troppmair J., and Wachter H. Immune response associated production of neopterin - Release from macrophages primarily under control of interferon-gamma. J. Exp. Med. 160 (1984) 310-316
12. Wachter H., Fuchs D., Hausen A., Reibnegger G., and Werner E.R. Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application. Adv. Clin. Chem. 27 (1989) 81-141
13. Muller M.M., Curtis H., Herold M., and Huber C.H. Neopterin in clinical practice. Clin. Chim. Acta. 201 (1991) 1-16
14. Tatzber F., Rabl H., Koriska K., Erhart U., Puhl H., Weag G., Krebs A., and Esterbauer H. Elivated serum neopterin levels in atherosclerosis. Atherosclerosis 89 (1991) 203-208
15. Erren M., Reinecke H., Junker R., Fobker M., Schulte H., Schurek J.O., Kropf J., Kerber S., Breithardt G., Assmann G., and Cullen P. Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler. Thomb. Vasc. Biol. 10 (1999) 2355-2363
16. Ilhan F., Akbulut H., Karaca I., Godekmerdan A., Ilkay E., and Bulut V. Procalcitonin, C-reactive protein and neopterin levels in patients with coronary atherosclerosis. Acta. Cardiol. 60 (2005) 361-365
17. Gieseg S.P., Cruz T., Glubb D., Muzghal D., and Whybrow J. 7,8 dihydroneopterin can protect cells from free radical mediated damage. Free. Radic. Biol. Med. 25 (1998) 32
18. Gieseg S.P., Duggan S., Rait C., and Platt A. Protein and thiol oxidation in cells exposed to peroxyl radicals, is inhibited by the macrophage synthesised pterin 7,8-dihydroneopterin. Biochim. Biophys. Acta 1591 (2002) 139-145
19. Baird S.K., Reid L., Hampton M., and Gieseg S.P. OxLDL induced cell death is inhibited by the macrophage synthesised pterin, 7,8-dihydroneopterin, in U937 cells but not THP-1 cells. Biochim. Biophys. Act. 1745 (2005) 361-369
20. Gieseg S.P., Reibnegger G., Wachter H., and Esterbauer H. 7,8-Dihydroneopterin inhibits low density lipoprotein oxidation in vitro. Evidence that this macrophage secreted pteridine is an antioxidant. Free. Radic. Res. 23 (1995) 123-136
21. Herpfer I., Greilberger J., Ledinski G., Widner B., Fuchs D., and Jurgens G. Neopterin and 7,8-dihydroneopterin interfere with low density lipoprotein oxidation mediated by peroxynitrite and/or copper. Free. Radic. Res. 36 (2002) 509-520
22. Gieseg S.P., Pearson J., and Firth C.A. Protein hydroperoxides are a major product of low density lipoprotein oxidation during copper, peroxyl radical and macrophage-mediated oxidation. Free. Radic. Res. 37 (2003) 983-991
23. Greilberger J., Oettl K., Cvirn G., Reibnegger G., and Jurgens G. Modulation of LDL oxidation by 7,8-dihydroneopterin. Free. Radic. Res. 38 (2004) 9-17
24. Gieseg S.P., and Cato S. Inhibition of THP-1 cell-mediated low-density lipoprotein oxidation by the macrophage-synthesised pterin, 7,8-dihydroneopterin. Redox. Report. 8 (2003) 113-119
25. Gieseg S.P., Maghzal G., and Glubb D. Inhibition of haemolysis by the macrophage synthesized antioxidant, 7,8-dihydroneopterin. Redox. Report. 5 (2000) 97-100
26. Widner B., Mayr C., Wirleitner B., and Fuchs D. Oxidation of 7,8-dihydroneopterin by hypochlorous acid yields neopterin. Biochem. Biophys. Res. Commun. 275 (2000) 307-311
27. Gieseg S.P., Whybrow J., Glubb D., and Rait C. Protection of U937 cells from free radical damage by the macrophage synthesized antioxidant 7,8 dihydroneopterin. Free. Radic. Res. 35 (2001) 311-318
28. Jurgens G., Lang J., and Esterbauer H. Modification of human low-density lipoprotein by the lipid peroxidation product 4-hydroxynonenal. Biochim. Biophys. Acta. 875 (1986) 103-114
29. Steinbrecher U.P., Lougheed M., Kwan W.C., and Dirks M. Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation. J. Biol. Chem. 264 (1989) 15216-15223
30. Zhang H., Yang Y., and Steinbrecher U.P. Structural requirements for macrophage binding of modified proteins to the scavenger receptor of macrophages. J. Biol. Chem. 268 (1993) 5535-5542
31. Obama T., Kato R., Masuda Y., Takahashi K., Aiuchi T., and Itabe H. Proteomics 7 (2007) 2132-2141
32. Simpson J.A., Narita S., Gieseg S.P., Gebicki S., Gebicki J.M., and Dean R.T. Long-lived reactive species on free-radical-damaged proteins. Biochem. J. 282 (1992) 621-624
33. Dean R.T., Gieseg S.P., and Davies M.J. Reactive species and their accumulation on radical-damaged proteins. Trends. Biochem. Sci. 18 (1993) 437-441
34. Davies M.J., Fu S., and Dean R.T. Protein hydroperoxides can give rise to reactive free radicals. Biochem. J. 305 (1995) 643-649
35. Gieseg S.P., Duggan S., and Gebicki J.M. Peroxidation of proteins before lipids in U937 cells exposed to peroxyl radicals. Biochem. J. 350 (2000) 215-218
36. Du J., and Gebicki J.M. Proteins are major initial cell targets of hydroxyl free radicals. Int. J. Biochem. Cell. Biol. 36 (2004) 2334-2343
37. Hawkins C.L., and Davies M.J. Generation and propagation of radical reactions on proteins. Biochimica. Et. Biophysica. Acta-Bioenergetics. 1504 (2001) 196-219
38. Firth C.A., Yang Y., and Gieseg S.P. Lipid oxidation predominates over protein hydroperoxide formation in human monocyte-derived macrophages exposed to aqueous peroxyl radicals. Free. Radic. Res. 41 (2007) 839-848
39. Chung B.H., Segrest J.P., Ray M.J., Brunzell J.D., Hokanson J.E., Krauss R.M., Beaudrie K., and Cone J.T. Single vertical spin density gradient centrifugation. Meth. Enzymol. 128 (1986) 181-209
40. Gieseg S.P., and Esterbauer H. Low density lipoprotein is saturable by pro-oxidant copper. FEBS. Lett. 343 (1994) 188-194
41. Graham A., Wood J.L., O'leary V.J., and Stone D. Human (THP-1) macrophages oxidise LDL by a thiol-dependent mechanism. Free. Radic. Res. 21 (1994) 295-308
42. Gay C., Collins J., and Gebicki J. Hydroperoxide assay with the ferric-xylenol orange complex. Anal. Biochem. 273 (1999) 149-155
43. Quinlan G.J., Evans T.W., and Gutteridge J.M.C. Oxidative damage to plasma proteins in adult respiratory distress syndrome. Free. Rad. Res. 20 (1994) 289-298
44. Draper H.H., Squires E.J., Mahmoodi H., Wu J., Agarwal S., and Hadley M. A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free. Radic. Biol. Med. 15 (1993) 353-363
45. Jentzsch A.M., Bachmenn H., Furst P., and Biesalski H.K. Improved analysis of malondialdehyde in human body fluids. Free. Radic. Biol. Med. 20 (1996) 251-256
46. Esterbauer H., Jurgens G., Quehenberger O., and Koller E. Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J. Lipid. Res. 28 (1987) 495-509
47. Gieseg S.P., Glubb D., and Maghzal G. Protection of erythrocytes by the macrophage synthesized antioxidant 7,8 dihydroneopterin. Free. Radic. Res. 34 (2001) 123-136
48. Rook G.A.W., Steele J., Umar S., and Dockrell H.M. A simple method for the solubilization of reduced NBT, and its use as a colorimetric assay for activation of human macrophages by gamma-interferon. J. Immunol. Methods. 82 (1985) 161-167
49. Boyne A.F., and Ellman G.L. A methodology for analysis of tissue sulfhydryl components. Anal. Biochem. 46 (1971) 639-653
50. Baoutina A., Dean R.T., and Jessup W. Trans-plasma membrane electron transport induces macrophage mediated low density lipoprotein oxidation. FASEB. J. 15 (2001) 1580-1582
51. Dean R.T., Fu S., Stocker R., and Davies M.J. Biochemistry and pathology of radical-mediated protein oxidation. Biochem. J. 324 (1997) 1-18
52. Sparrow C.P., and Olszewski J. Cellular oxidation of low density lipoprotein is caused by thiol production in media containing transition metal ions. J. Lipid. Res. 34 (1993) 1219-1228
53. Kojima S., Nomura T., Icho T., Kajiwara Y., Kitabatake K., and Kubota K. Inhibitory effects of neopterin on NADPH-dependent superoxide-generating oxidase of rat peritoneal macrophages. FEBS. Lett. 329 (1993) 125-128
54. Wirleitner B., Obermoser G., Bock G., Neurauter G., Schennach H., Sepp N., and Fuchs D. Induction of apoptosis in human blood T cells by 7,8-dihydroneopterin: the difference between healthy controls and patients with systemic lupus erythematosus. Clin. Immunol. 107 (2003) 152-159
55. Margreiter J., Schlager A., Balogh A., Maier H., Balogh D., Lindner K.H., Fuchs D., and Schobersberger W. Exogenous neopterin causes cardiac contractile dysfunction in the isolated perfused rat heart. J. Mol. Cell. Cardiol. 32 (2000) 1265-1274
56. Rieder J., Lirk P., and Hoffmann G. Neopterin as a potential modulator of tumor cell growth and proliferation. Med. Hypotheses. 60 (2003) 531-534
57. Esterbauer H., Rotheneder M., Striegl G., Waeg G., Ashy A., Sattler W., and Jurgens G. Vitamin E and other lipophilic antioxidants protect LDL against oxidation. Fat. Sci. Technol. 91 (1989) 316-324
58. Bisby R.H., and Parker A.W. Reaction of ascorbate with the alpha-tocopheroxyl radical in micellar and bilayer-membrane systems. Arch. Biochem. Biophys. 317 (1995) 170-178
59. Roubal W.T., and Tappel A.L. Damage to proteins, enzymes, and amino acids by peroxidizing lipids. Arch. Biochem. Biophys. 113 (1966) 5-8
60. Refsgaard H.H.F., Tsai L., and Stadtman E.R. Modifications of proteins by polyunsaturated fatty acid peroxidation products. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 611-616
61. Yan L.J., Lodge J.K., Traber M.G., and Packer L. Apolipoprotein B carbonyl formation is enhanced by lipid peroxidation during copper-mediated oxidation of human low-density lipoproteins. Arch. Biochem. Biophys. 339 (1997) 165-171
62. Sukhanov S., Higashi Y., Shai S.Y., Itabe H., Ono K., Parthasarathy S., and Delafontaine P. Novel effect of oxidized low-density lipoprotein - cellular ATP depletion via downregulation of glyceraldehyde-3-phosphate dehydrogenase. Circ. Res. 99 (2006) 191-200
63. Schlesinger P., Watson B.M., Cotton R.G.H., and Danks D.M. Urinary dihydroxanthopterin in the diagnosis of malignant hyperphenylalaninemia and phenylketonuria. Clin. Chim. Acta. 92 (1979) 187-195
64. Cirillo P., Pacileo M., De Rosa S., Calabro P., Gargiulo A., Angri V., Granato-Corigliano F., Fiorentino I., Prevete N., De Palma R., Mauro C., Leonardi A., and Chiariello M. Neopterin induces pro-atherothrombotic phenotype in human coronary endothelial cells. J. Thromb. Haemostasis 4 (2006) 2248-2255
65. Hazen S.L., and Heinecke J.W. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J. Clin. Invest. 99 (1997) 2075-2081
66. Woods A.A., Linton S.M., and Davies M.J. Detection of HOCl-mediated protein oxidation products in the extracellular matrix of human atherosclerotic plaques. Biochem. J. 370 (2003) 729-735
67. Hazen S.L., Zhang R., Shen Z., Wu W., Podrez E.A., MacPherson J.C., Schmitt D., Mitra S.N., and Mukhopadhyay C. Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes: pathways for monocyte-mediated protein nitration and lipid peroxidation in vivo. Circ. Res. 85 (1999) 950-958